• Guidance in managing pre-existing heart disease during cancer treatment
• Prevention , early detection and management of cardiotoxicity that may occur from a wide range of cancer treatments , including chemotherapy , targeted therapy , immunotherapy , cellular therapy , and radiation therapy
• Preventive care and cardiac monitoring for those at risk of long-term cardiotoxicity in survivorship , including patients with exposure to radiation , hormone therapy , bone marrow transplants , and certain chemotherapies
• Medication
• Chemotherapy
• Blood stem cell transplant
• Liver transplant
• Kidney transplant
• Clinical trials Related published article
• Cardioprotective treatment
• Cardiotoxicity risk assessment
• Cardiovascular risk factor optimization
• Cardiac biomarker monitoring
• Advanced multi-modality cardiac imaging surveillance
15
Cardio-Oncology Center
In addition to traditional chemotherapy , novel cancer therapies have a wide range of potential cardiotoxicity during and after cancer treatment , including hypertension , heart rhythm disorders , obstructive coronary artery disease , and cardiomyopathies or weakened heart muscle .
Through a collaborative approach with oncologists , cardiologists , and other providers , the Cardio- Oncology Center at Baylor Scott & White Heart and Vascular Hospital – Dallas is committed to individualized care throughout the cancer spectrum , including :
• Guidance in managing pre-existing heart disease during cancer treatment
• Prevention , early detection and management of cardiotoxicity that may occur from a wide range of cancer treatments , including chemotherapy , targeted therapy , immunotherapy , cellular therapy , and radiation therapy
• Preventive care and cardiac monitoring for those at risk of long-term cardiotoxicity in survivorship , including patients with exposure to radiation , hormone therapy , bone marrow transplants , and certain chemotherapies
Led by the center ’ s medical director and board-certified cardio-oncologist , Courtney M . Campbell , MD , PhD , FACC , the team works closely with providers and their patients . Coordinated by a nurse navigator , patients benefit from the combined power of expertise in two disciplines — cardiology and oncology — with proven approaches .
Amyloidosis program
The amyloidosis program in Dallas offers a customized plan of care for primary amyloidosis and hereditary amyloidosis led by a multidisciplinary team of specialists , including advanced heart failure and transplant cardiologists and a cardio-oncologist . Advanced treatment options include :
• Medication
• Chemotherapy
• Blood stem cell transplant
• Liver transplant
• Kidney transplant
• Clinical trials Related published article
Obici L , Ajroud-Driss S , Lin KP , Berk JL , Gillmore JD , Kale P , Koike H , Danese D , Aldinc E , Chen C , Vest J , Adams D ; HELIOS-A Collaborators Study Group . Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin- Mediated Amyloidosis with Polyneuropathy . Neurol Ther . 2023 Jul 31 .
For more information about the Cardio-Oncology Center or to refer a patient : 214.820.7162 , CardioOncologyCenter @ BSWHealth . org
Baylor Scott & White Heart and Vascular Hospital - Dallas | ADVANCED CARDIOVASCULAR CENTERS
Ongoing surveillance and diagnostics Cardio-oncology evaluations include individually customized , comprehensive monitoring plans with :
• Cardioprotective treatment
• Cardiotoxicity risk assessment
• Cardiovascular risk factor optimization
• Cardiac biomarker monitoring
• Advanced multi-modality cardiac imaging surveillance